Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Clinical trial NCT05063318 · COMPLETED

Trial details

NCT number: NCT05063318
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2020-10-07
Primary completion: 2022-04-21
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.